Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PROMEDIOR INC

Home Clinical Trial Sponsors and OrganizationsPROMEDIOR INC

PROMEDIOR INC

371 Phoenixville Pike, Malvern, Pennsylvania, United States

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

5 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

2

33.3%

Trial Status Distribution

Active, not recruiting

5

83.3%

Completed

1

16.7%

Clinical Trials

Trials sponsored by this organization (6)

A study to test intravenous PRM-151 for safety and to see how PRM-151 acts in the body and blood of people with idiopathic pulmonary fibrosis (IPF) - a disorder where lung tissue becomes damaged and scarred making it difficult to breathe.

Active, not recruiting

Dec 201460 participants

Glaucoma Surgery Scarring Prevention Study

Active, not recruiting

Oct 2010120 participants

Glaucoma Surgery Scarring Prevention Study

Active, not recruiting

Apr 2010120 participants

Glaucoma Surgery Scarring Prevention Study

Active, not recruiting

Mar 2010120 participants

Glaucoma Surgery Scarring Prevention Study

Active, not recruiting

Jan 2010120 participants

A Randomized, Double-Masked, Sponsor-Unmasked, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRM-151 Administered Intravenously to Patients with Idiopathic Pulmonary Fibrosis

12 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials6
Approvals
News

Back to Organizations